Trial Profile
Continuous insulin infusion +/- liraglutide in newly-diagnosed type 2 diabetics
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Jul 2013
Price :
$35
*
At a glance
- Drugs Liraglutide (Primary) ; Insulin
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 03 Jul 2013 New trial record
- 25 Jun 2013 Results presented at the 73rd Annual Scientific Sessions of the American Diabetes Association.